Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1-AKT interaction

被引:57
作者
Fang, Xian-Ying [1 ]
Chen, Wei [1 ]
Fan, Jun-Ting [2 ]
Song, Ran [1 ]
Wang, Lu [1 ]
Gu, Yan-Hong [3 ]
Zeng, Guang-Zhi [2 ]
Shen, Yan [1 ]
Wu, Xue-Feng [1 ]
Tan, Ning-Hua [2 ]
Xu, Qiang [1 ]
Sun, Yang [1 ]
机构
[1] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China
[2] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources W China, Kunming Inst Bot, Kunming 650201, Peoples R China
[3] Nanjing Med Univ, Dept Clin Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
RA-V; Cyclopeptide; Mitochondrial apoptosis pathway; PI3K/AKT; Breast cancer; ENDOPLASMIC-RETICULUM STRESS; CYCLIC HEXAPEPTIDES; INHIBITION; PATHWAY; PHOSPHORYLATION; ANGIOGENESIS; INVOLVEMENT; SENSITIVITY; INDUCTION; PI3K/AKT;
D O I
10.1016/j.taap.2012.12.010
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
In the present paper, we examined the effects of a natural cyclopeptide RA-V on human breast cancer cells and the underlying mechanisms. RA-V significantly inhibited the growth of human breast cancer MCF-7, MDA-MB-231 cells and murine breast cancer 4T1 cells. In addition, RA-V triggered mitochondria] apoptotic pathway which was indicated by the loss of mitochondrial membrane potential, the release of cytochrome c, and the activation of caspase cascade. Further study showed that RA-V dramatically inhibited phosphorylation of AKT and 3-phosphoinositide dependent protein kinase 1 (PDK1) in MCF-7 cells. Moreover, RA-V disrupted the interaction between PDK1 and AKT in MCF-7 cells. Furthermore, RA-V-induced apoptosis could be enhanced by phosphatidylinositol 3-kinase inhibitor or attenuated by over-expression of AKT in all the three kinds of breast cancer cells. Taken together, this study shows that RA-V, which can induce mitochondria-mediated apoptosis, exerts strong anti-tumor activity against human breast cancer. The underlying anti-cancer mechanism of RA-V is related to the blockage of the interaction between PDK1 and AKT. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:95 / 103
页数:9
相关论文
共 40 条
[1]
Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition [J].
Calleja, Veronique ;
Laguerre, Michel ;
Parker, Peter J. ;
Larijani, Banafshe .
PLOS BIOLOGY, 2009, 7 (01) :189-200
[2]
Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain [J].
Chakraborty, Anutosh ;
Koldobskiy, Michael A. ;
Bello, Nicholas T. ;
Maxwell, Micah ;
Potter, James J. ;
Juluri, Krishna R. ;
Maag, David ;
Kim, Seyun ;
Huang, Alex S. ;
Dailey, Megan J. ;
Saleh, Masoumeh ;
Snowman, Adele M. ;
Moran, Timothy H. ;
Mezey, Esteban ;
Snyder, Solomon H. .
CELL, 2010, 143 (06) :897-910
[3]
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy [J].
Chang, F ;
Lee, JT ;
Navolanic, PM ;
Steelman, LS ;
Shelton, JG ;
Blalock, WL ;
Franklin, RA ;
McCubrey, JA .
LEUKEMIA, 2003, 17 (03) :590-603
[4]
Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif [J].
Colombo, G ;
Curnis, F ;
De Mori, GMS ;
Gasparri, A ;
Longoni, C ;
Sacchi, A ;
Longhi, R ;
Corti, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :47891-47897
[5]
Breast cancer statistics, 2011 [J].
DeSantis, Carol ;
Siegel, Rebecca ;
Bandi, Priti ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (06) :409-418
[6]
Targeted therapies in breast cancer: Where are we now? [J].
Di Cosimo, Serena ;
Baselga, Jose .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) :2781-2790
[7]
Rubiyunnanins C-H, cytotoxic cyclic hexapeptides from Rubia yunnanensis inhibiting nitric oxide production and NF-κB activation [J].
Fan, Jun-Ting ;
Su, Jia ;
Peng, Yan-Min ;
Li, Yan ;
Li, Jia ;
Zhou, Yu-Bo ;
Zeng, Guang-Zhi ;
Yan, He ;
Tan, Ning-Hua .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (23) :8226-8234
[8]
Effective oral chemotherapy for breast cancer:: pillars of strength [J].
Findlay, M. ;
von Minckwitz, G. ;
Wardley, A. .
ANNALS OF ONCOLOGY, 2008, 19 (02) :212-222
[9]
PI3K/Akt and apoptosis: size matters [J].
Franke, TF ;
Hornik, CP ;
Segev, L ;
Shostak, GA ;
Sugimoto, C .
ONCOGENE, 2003, 22 (56) :8983-8998
[10]
Programmed Cell Death in Animal Development and Disease [J].
Fuchs, Yaron ;
Steller, Hermann .
CELL, 2011, 147 (04) :742-758